Molecular tumor board guides treatment in advanced sarcoma but benefits few patients
A retrospective study of 125 advanced sarcoma patients found molecular tumor board recommendations led to treatment in 32.8 percent, with ...
A retrospective study of 125 advanced sarcoma patients found molecular tumor board recommendations led to treatment in 32.8 percent, with ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.